Product image of Irbesartan Combix (Irbesartan) supplied by GNH India

Irbesartan Combix

Active Ingredient:
Irbesartan
Origin:
EU

Irbesartan Combix (Irbesartan)

Irbesartan, the active ingredient in Irbesartan Combix, is an Angiotensin II receptor blocker presented as an oral tablet for oral use. It treats hypertension and diabetic nephropathy in adult patients.

GNH India supplies Irbesartan Combix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Laboratorios Combix, S.L.U.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Irbesartan Combix belongs to the Angiotensin II receptor blocker class and is used to manage conditions related to the renin‑angiotensin system.

  • Hypertension: lowers elevated blood pressure and reduces cardiovascular risk.
  • Diabetic nephropathy: slows progression of kidney damage in patients with type 2 diabetes.
  • Proteinuria associated with diabetic kidney disease: reduces urinary protein excretion, supporting renal protection.

How It Works

  • Irbesartan selectively antagonizes angiotensin II type 1 (AT1) receptors, preventing angiotensin II‑mediated vasoconstriction, aldosterone release, and sympathetic activation. By blocking this pathway, it promotes vasodilation, reduces sodium and water retention, and lowers systemic vascular resistance, leading to decreased blood pressure and renal protective effects.

Side Effects

Common side effects are generally mild and transient.

Common Side Effects

  • Dizziness: sensation of light‑headedness, especially after standing.
  • Headache: mild to moderate pain in the head region.
  • Fatigue: feeling unusually tired or weak.
  • Hyperkalemia: elevated potassium levels in the blood.
  • Upper respiratory tract infection: nasopharyngitis or mild cough.
  • Diarrhea: loose stools occurring intermittently.

Serious or Rare Side Effects

  • Angioedema: swelling of the face, lips, tongue, or throat that may impair breathing.
  • Acute renal impairment: sudden decline in kidney function.
  • Hepatic injury: signs of liver dysfunction such as jaundice.
  • Severe hypotension: markedly low blood pressure causing faintness or shock.

Precautions & Warnings

Before initiating therapy, clinicians should assess patient‑specific factors and monitor relevant parameters.

  • Blood pressure monitoring: check regularly to ensure therapeutic control.
  • Renal function assessment: evaluate serum creatinine and eGFR before and during treatment.
  • Serum potassium surveillance: monitor especially when combined with potassium‑sparing agents.
  • Hepatic impairment caution: adjust use in patients with liver disease.
  • Pregnancy avoidance: discontinue if pregnancy is confirmed or planned.
  • Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Irbesartan may interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

  • Aliskiren in diabetic patients: combined use can increase risk of renal dysfunction.
  • Dual blockade with ACE inhibitors or other ARBs: may cause excessive hypotension and hyperkalemia.
  • Potassium‑sparing diuretics (e.g., spironolactone): heightens risk of hyperkalemia.
  • NSAIDs (high‑dose or chronic): can impair renal function and blunt antihypertensive effect.

Moderate Interactions (Monitor Closely)

  • Thiazide diuretics: may enhance antihypertensive effect, requiring dose adjustment.
  • Lithium: increased lithium levels and potential toxicity.
  • CYP3A4 inhibitors (e.g., ketoconazole): may raise irbesartan plasma concentrations.

Frequently Asked Questions

Irbesartan Combix is prescribed to lower high blood pressure (hypertension) and to protect kidney function in adults with diabetic nephropathy, helping to slow disease progression and reduce protein loss in the urine.

Irbesartan blocks angiotensin II type 1 (AT1) receptors, preventing the hormone from causing blood vessels to narrow and from stimulating aldosterone release. This results in vasodilation, reduced fluid retention, and lower blood pressure, while also offering renal protective effects.

The appropriate dose of Irbesartan Combix is determined by the prescribing clinician based on the patient’s medical condition, response to therapy, and any concurrent medications. Dosage adjustments are made according to clinical guidelines.

The safety of Irbesartan Combix in pregnancy is not established, and it is generally avoided because of potential fetal harm. Limited data exist for breastfeeding; the decision to use it while nursing should be made by a healthcare professional weighing risks and benefits.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Irbesartan belongs to the ARB class, which offers blood‑pressure control similar to ACE inhibitors but with a lower incidence of cough and angioedema. Compared with calcium‑channel blockers or diuretics, ARBs provide a distinct mechanism focused on the renin‑angiotensin system, making them useful in patients with renal concerns or ACE‑inhibitor intolerance.

Irbesartan Combix should be stored at temperatures below 25 °C, in its original packaging, protected from moisture and direct sunlight. Keeping the product in a dry, cool environment maintains its stability and potency.

Irbesartan Combix is taken orally, usually once daily, with or without food. The tablet should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed by a healthcare provider.

Serious risks include angioedema (swelling of the face, lips, tongue, or throat), severe hypotension, acute kidney injury, and hyperkalemia. Patients should seek immediate medical attention if they experience swelling, difficulty breathing, sudden drop in blood pressure, or signs of kidney dysfunction.

Irbesartan Combix should be avoided in patients with known hypersensitivity to irbesartan or any component of the formulation, in those who are pregnant, and in individuals with severe hepatic impairment unless specifically directed by a physician.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Irbesartan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT